Use of APL-type peptide for treating intestinal inflammatory diseases and type 1 diabetes

Details for Australian Patent Application No. 2012100293 (hide)

Owner Centro De Ingenieria Genetica Y Biotecnologia

Inventors Barbera Betancourt, Ariana; Dominguez Horta, Maria del Carmen; Lorenzo Perez, Norailys; Padron Palomares, Gabriel Ramon; Falcon Cama, Viviana; Menendez Valdes, Ivon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012100293

Parent 2009335405

Filing date 16 March 2012

Opi date 12 April 2012

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

5 April 2012 Innovation Patent Application Filed

12 April 2012 Innovation Patent Open to Public Inspection

  Published as AU-A-2012100293

12 April 2012 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012100294-Cage For Handling Or Storing Goods

2012100292-A banner